Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid is a synthetic small molecule belonging to the class of phenylpyridines and naphthyridine derivatives. It has a molecular formula of C21H13N3O4 and a molecular weight of approximately 371.35 g/mol[1][2][5]. The compound features a naphthyridine ring system substituted with a nitrophenyl group and benzoic acid moiety[4]. It is classified as an experimental compound with no approved medical indications or known clinical use as of June 2025[1]. There are no reported clinical trials or patents for this molecule[1]. Its mechanism of action is not established in the literature; however, related naphthyridine derivatives have been studied for potential activity against phosphodiesterase enzymes (PDEs), but there is no direct evidence that this specific compound acts on any particular target.
- Other names
- 4-(8-(3-nitrophenyl)-1,7-naphthyridin-6-yl)benzoic acidBenzoic acid, 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]-
02
Targets
PDE4APDE4B (3',5'-cyclic-AMP phosphodiesterase 4B)PDE4D (Phosphodiesterase 4D)
Beyond the preview
Go deeper on 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid.